Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
F 12.25 -2.00% -0.25
AGL closed down 2.0 percent on Wednesday, April 17, 2024, on 17 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -2.00%
NR7 Range Contraction -2.00%
Narrow Range Bar Range Contraction -2.00%
Earnings Movers Other -2.00%
Inside Day Range Contraction -2.00%
Calm After Storm Range Contraction -3.92%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 7 hours ago
Down 3% about 7 hours ago
Outside Day about 7 hours ago
Gap Down Closed about 9 hours ago
Reversed from Down about 9 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Angle Plc Description

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Cancer Medical Specialties Monitoring Nature Clinical Medicine Oncology Fluid Offers Products Blood Drug Development Tumor Personalized Cancer Anatomical Pathology Biopsy Circulating Tumor Cell Medical Diagnostic

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 37.4
52 Week Low 9.0667
Average Volume 1,220,613
200-Day Moving Average 14.06
50-Day Moving Average 15.04
20-Day Moving Average 13.03
10-Day Moving Average 13.15
Average True Range 1.20
RSI (14) 40.83
ADX 19.36
+DI 24.70
-DI 17.54
Chandelier Exit (Long, 3 ATRs) 13.15
Chandelier Exit (Short, 3 ATRs) 15.09
Upper Bollinger Bands 14.72
Lower Bollinger Band 11.34
Percent B (%b) 0.27
BandWidth 25.97
MACD Line -0.59
MACD Signal Line -0.63
MACD Histogram 0.0446
Fundamentals Value
Market Cap 31.92 Million
Num Shares 261 Million
EPS -0.09
Price-to-Earnings (P/E) Ratio -136.11
Price-to-Sales 23.44
Price-to-Book 1.33
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.25
Resistance 3 (R3) 13.30 13.02 13.08
Resistance 2 (R2) 13.02 12.77 12.99 13.03
Resistance 1 (R1) 12.64 12.61 12.50 12.58 12.97
Pivot Point 12.36 12.36 12.29 12.33 12.36
Support 1 (S1) 11.97 12.10 11.83 11.92 11.53
Support 2 (S2) 11.69 11.94 11.66 11.47
Support 3 (S3) 11.31 11.69 11.42
Support 4 (S4) 11.25